Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs Limited has informed the stock exchanges about the newspaper publication of its Standalone and Consolidated Unaudited Financial Results for the quarter ended June 30, 2025. The results were published in Financial Express (English) and Loksatta-Jansatta (Gujarati) on Thursday, August 14, 2025. This filing is being made under Regulation 30 and 47 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015, to comply with mandatory public disclosure norms. The document itself only contains copies of the newspaper clippings, not the detailed financial figures.
This is a routine regulatory compliance filing and does not contain new financial information or any material business update. Investors should refer to the company's actual Q1 FY26 results for performance details; no immediate impact on share price is expected from this announcement alone.